Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phibro Animal Health (PAHC)
NASDAQ:PAHC
Holding PAHC?
Track your performance easily
PAHC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.49 - $25.98
Previous Close$23.74
Volume193.23K
Average Volume (3M)199.56K
Market Cap
$961.56M
Enterprise Value$1.35B
Total Cash (Recent Filing)$89.84M
Total Debt (Recent Filing)$474.17M
Price to Earnings (P/E)55.3
Beta0.97
Next Earnings
Feb 05, 2025EPS Estimate
$0.43Next Dividend Ex-Date
Nov 27, 2024Dividend Yield2.02%
Share Statistics
EPS (TTM)0.43
Shares Outstanding40,503,608
10 Day Avg. Volume244,270
30 Day Avg. Volume199,565
Standard Deviation0.11
R-Squared0.06
Alpha0.00097
Financial Highlights & Ratios
Price to Book (P/B)3.67
Price to Sales (P/S)0.92
Price to Cash Flow (P/CF)19.10
P/FCF Ratio75.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.34
Enterprise Value/Gross Profit4.51
Enterprise Value/Ebitda21.96
Forecast
1Y Price Target
$20.75Price Target Upside-14.04% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering4
Phibro Animal Health News
PremiumCompany Announcements
Phibro Animal Health Announces Leadership Transition PlansPremiumCompany Announcements
Phibro Animal Health Reports Strong Q1 Performance
PremiumPre-Earnings
Is PAHC a Buy, Before Earnings?
PremiumCompany Announcements
Phibro Animal Health Expands Portfolio with Zoetis Acquisition
Bulls Say, Bears Say
Bulls Say
AcquisitionPhibro's acquisition of ZTS's MFA business is set to expand its portfolio, increase scale, and improve the margin profile of the business, marking a strategic growth move.
Financial PerformancePAHC reported impressive F4Q results with sales of $273 million and an adjusted EPS of 41 cents, both surpassing expectations and indicating strong financial health.
Operational EfficiencyA new operational efficiency initiative, Phibro Forward, has been announced to improve topline growth and profitability, showcasing a proactive approach to enhancing business performance.
Bears Say
Financial PerformancePAHC's margins are below most animal health peers, influenced by mix and non-animal health divisions, and have been under pressure over the past few years.
Growth And ProfitabilityBusiness's lack of operating leverage and muted profitability with its current mix relative to Animal Health peers.
Stock ValuationPAHC shares trade at a discount to animal health peers, reflecting differences in portfolios and growth profiles, as well as investor caution around execution.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PAHC FAQ
What was Phibro Animal Health’s price range in the past 12 months?
Phibro Animal Health lowest stock price was $9.49 and its highest was $25.98 in the past 12 months.
What is Phibro Animal Health’s market cap?
Currently, no data Available
When is Phibro Animal Health’s upcoming earnings report date?
Phibro Animal Health’s upcoming earnings report date is Feb 05, 2025 which is in 71 days.
How were Phibro Animal Health’s earnings last quarter?
Phibro Animal Health released its earnings results on Nov 06, 2024. The company reported $0.35 earnings per share for the quarter, beating the consensus estimate of $0.248 by $0.102.
Is Phibro Animal Health overvalued?
According to Wall Street analysts Phibro Animal Health’s price is currently Overvalued.
Does Phibro Animal Health pay dividends?
Phibro Animal Health pays a Quarterly dividend of $0.12 which represents an annual dividend yield of 2.02%. See more information on Phibro Animal Health dividends here
What is Phibro Animal Health’s EPS estimate?
Phibro Animal Health’s EPS estimate is $0.43.
How many shares outstanding does Phibro Animal Health have?
Phibro Animal Health has 20,337,574 shares outstanding.
What happened to Phibro Animal Health’s price movement after its last earnings report?
Phibro Animal Health reported an EPS of $0.35 in its last earnings report, beating expectations of $0.248. Following the earnings report the stock price went up 1.776%.
Which hedge fund is a major shareholder of Phibro Animal Health?
Among the largest hedge funds holding Phibro Animal Health’s share is Brandes Investment Partners LP. It holds Phibro Animal Health’s shares valued at 33M.
---
Phibro Animal Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$20.75 (-14.04% Downside)
$20.75 (-14.04% Downside)
Blogger Sentiment
Bullish
PAHC Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $100.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 12.0%
Last 30 Days ▼ 6.2%
Last 30 Days ▼ 6.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
137.89%
12-Months-Change
Fundamentals
Return on Equity
6.55%
Trailing 12-Months
Asset Growth
0.18%
Trailing 12-Months
Company Description
Phibro Animal Health
Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment comprises of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment offers production of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
---
PAHC Company Deck
---
PAHC Earnings Call
Q1 2024
0:00 / 0:00
---
PAHC Stock 12 Month Forecast
Average Price Target
$20.75
▼(-14.04% Downside)
Technical Analysis
Best Analysts Covering PAHC
1 Year
1 Year Success Rate
6/12 ratings generated profit
1 Year Average Return
-21.77%
reiterated a sell rating 15 days ago
Copying Balaji Prasad's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -21.77% per trade.
---